Library

Since 2008, ECDC and the WHO Regional Office for Europe (WHO/Europe) have coordinated enhanced HIV/AIDS surveillance in Europe with the purpose of covering all 53 countries in the European region. The annual surveillance reports are launched each World AIDS Day, 1 December.

This report aims to describe basic trends and epidemiological features of both diseases across countries in the European Union and European Economic Area for the years 2006 to 2011.

This film is designed to help people to identify ways to reduce potential harms resulting from injecting. The film is aimed at people who inject heroin (specifically, the brown heroin commonly available in the UK), but many of the steps shown can be applied to the injection of other drugs.

Detailed analysis of the epidemiological information available on HCV prevalence and genotype distribution for 16 countries in the European region

Présentation des actions et des activités du réseau en 2012

The American Association for the Study of Liver Diseases (AASLD) has released an update of the practice guideline on the Management of Adult Patients with Ascites Due to Cirrhosis last published in 2009 in the journal HEPATOLOGY. Cirrhosis is the eighth leading cause of death in the United States and ascites is the most common complication of cirrhosis.

En esta publicación podéis encontrar un resumen de las actividades de ASSCAT durante el 2012 y los siguientes artículos: Nueva web: www.asccat-hepatitis.org, Hepatitis C: la pandemia silenciosa, Día Mundial de la Hepatitis 2013, ASSCAT ha participado en la elaboración del Índice Europeosobre a Atención a la Hepatitis 2012,Fibroscan®: la tranquilidad de un diagnóstico indoloro y fiable para el paciente hepático, Screening-Hepatitis C en la Barceloneta, Medicaments, amics o enemics, Gracias por lo que me habéis enseñado, Sóc infermera y Acceso y diagnóstico ante la innovación terapéutica para la hepatitis C.

This independent public health report is intended to complement the work of the London Joint Working Group by reviewing services across London, and applying best evidence to the London context. The principle intended audience for this work is commissioners of health services and drug treatment services and it is hoped that the information provided will be of use in formulating future business cases for HCV services.

Use this website to check for potential drug interactions between drugs used in the treatment of hepatitis B and C and a very wide range of prescription medications. The website also contains extensive resources on the pharmacology of drugs used in viral hepatitis treatment.

This report sets out the status of hepatitis C in the capital and assesses current service provision at a local authority and NHS commissioner level.